skip to main content

زبان محتوا

پشتیبانی: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > alpha-l-fucosyl-(1->2)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(t18:0)(2-)
... > chemical entity > molecular entity > ion > anion > polyatomic anion > oxoanion > carboxylic acid anion > carbohydrate acid derivative anion > anionic ganglioside > alpha-l-fuc-(1->2)-beta-d-gal-(1->3)-beta-d-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(2-) > alpha-l-fucosyl-(1->2)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(t18:0)(2-)
... > chemical entity > molecular entity > ion > polyatomic ion > polyatomic anion > oxoanion > carboxylic acid anion > carbohydrate acid derivative anion > anionic ganglioside > alpha-l-fuc-(1->2)-beta-d-gal-(1->3)-beta-d-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(2-) > alpha-l-fucosyl-(1->2)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(t18:0)(2-)
... > chemical entity > molecular entity > polyatomic entity > polyatomic ion > polyatomic anion > oxoanion > carboxylic acid anion > carbohydrate acid derivative anion > anionic ganglioside > alpha-l-fuc-(1->2)-beta-d-gal-(1->3)-beta-d-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(2-) > alpha-l-fucosyl-(1->2)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(t18:0)(2-)
... > chemical entity > molecular entity > polyatomic entity > heteroatomic molecular entity > oxide > oxoanion > carboxylic acid anion > carbohydrate acid derivative anion > anionic ganglioside > alpha-l-fuc-(1->2)-beta-d-gal-(1->3)-beta-d-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(2-) > alpha-l-fucosyl-(1->2)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(t18:0)(2-)
... > chemical entity > molecular entity > ion > anion > organic anion > carboxylic acid anion > carbohydrate acid derivative anion > anionic ganglioside > alpha-l-fuc-(1->2)-beta-d-gal-(1->3)-beta-d-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(2-) > alpha-l-fucosyl-(1->2)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(t18:0)(2-)
... > chemical entity > molecular entity > ion > organic ion > organic anion > carboxylic acid anion > carbohydrate acid derivative anion > anionic ganglioside > alpha-l-fuc-(1->2)-beta-d-gal-(1->3)-beta-d-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(2-) > alpha-l-fucosyl-(1->2)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(t18:0)(2-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic ion > organic anion > carboxylic acid anion > carbohydrate acid derivative anion > anionic ganglioside > alpha-l-fuc-(1->2)-beta-d-gal-(1->3)-beta-d-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(2-) > alpha-l-fucosyl-(1->2)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(t18:0)(2-)

اصطلاح مرجح

alpha-l-fucosyl-(1->2)-beta-d-galactosyl-(1->3)-n-acetyl-beta-d-galactosaminyl-(1->4)-[n-acetyl-alpha-neuraminosyl-(2->8)-n-acetyl-alpha-neuraminosyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(t18:0)(2-)  

نوع

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

بار

  • -2

فرمول

  • C73H123N4O44R

جرم

  • 1760.761

جرم تک‌ایزوتوپی

  • 1759.75102

اسمایلٓ

  • [C@@]1(O[C@]([C@@H]([C@H](C1)O)NC(C)=O)([C@@H]([C@@H](CO)O)O)[H])(C([O-])=O)O[C@@H]([C@H]([C@@]2(O[C@](C[C@H](O)[C@H]2NC(=O)C)(C([O-])=O)O[C@H]3[C@H]([C@H](O[C@H]([C@@H]3O)O[C@@H]4[C@H](O[C@H]([C@@H]([C@H]4O)O)OC[C@@H]([C@@H]([C@@H](CCCCCCCCCCCCCC)O)O)NC(=O)*)CO)CO)O[C@H]5[C@@H]([C@H]([C@H]([C@H](O5)CO)O)O[C@@H]6O[C@@H]([C@@H]([C@@H]([C@H]6O[C@@H]7O[C@H]([C@H]([C@H]([C@@H]7O)O)O)C)O)O)CO)NC(C)=O)[H])O)CO

زیرمجموعه

  • 2_STAR

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:141760

این مفهوم را بارگیری کن: